[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Niagen Bioscience Inc (NAGE)

Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Niagen Bioscience Inc 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 USA

www.niagenbioscience.com Employees: 117 P: 310-388-6706

Sector:

Medical

Description:

Niagen Bioscience Inc. is a nicotinamide adenine dinucleotide science and healthy-aging research company. Niagen Bioscience Inc., formerly known as ChromaDex Corp., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 307,426
Enterprise Value, $K 242,636
Shares Outstanding, K 79,644
Float, K 71,680
% Float 90.00%
Short Interest, K 5,402
Short Float 6.78%
Days to Cover 7.95
Short Volume Ratio 0.56
% of Insider Shareholders 10.00%
% of Institutional Shareholders 15.41%

Financials:

Annual Sales, $ 129,420 K
Annual Net Income, $ 17,380 K
Last Quarter Sales, $ 31,470 K
Last Quarter Net Income, $ 6,320 K
EBIT, $ 11,110 K
EBITDA, $ 11,900 K

Growth:

1-Year Return -64.85%
3-Year Return 153.95%
5-Year Return -56.82%
5-Year Revenue Growth 118.39%
5-Year Earnings Growth 154.55%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.07 on 05/06/26
Next Earnings Date 08/05/26
Earnings Per Share ttm 0.19
EPS Growth vs. Prev Qtr 133.33%
EPS Growth vs. Prev Year 75.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 04/13/16

NAGE Ratios

Ratio
Price/Earnings ttm 20.21
Price/Earnings forward 17.72
Price/Earnings to Growth N/A
Return-on-Equity % 22.68%
Return-on-Assets % 16.23%
Profit Margin % 13.43%
Debt/Equity 0.00
Price/Sales 2.36
Price/Cash Flow 18.94
Price/Book 3.71
Book Value/Share 1.03
Interest Coverage -1.30
60-Month Beta 2.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.